ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
My ASX share portfolio is up 40% in 2024! Here's my strategy for 2025
Retirement
How I'd generate $80,000 of retirement income from ASX shares
Healthcare Shares
'Huge opportunity' ahead for this ASX 200 healthcare stock
Share Gainers
Here are the top 10 ASX 200 shares today
Blue Chip Shares
3 excellent ASX 200 blue chip shares to buy in 2025
Healthcare Shares
What's the diagnosis for ASX healthcare shares in 2025?
Healthcare Shares
Which insider sold $770,000 worth of ResMed shares this week?
Healthcare Shares
Here's the outlook on ResMed shares in 2025
Healthcare Shares
2 ASX healthcare shares that are screaming buys in December
How to invest
How I would generate $50,000 of retirement income from ASX shares
Healthcare Shares
Why is everyone talking about ResMed shares?
Blue Chip Shares
3 ASX shares Australians can buy and hold for the next decade
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.